These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25754460)

  • 1. Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform.
    Vaudano E; Vannieuwenhuyse B; Van Der Geyten S; van der Lei J; Visser PJ; Streffer J; Ritchie C; McHale D; Lovestone S; Hofmann-Apitius M; Truyen L; Goldman M
    Alzheimers Dement; 2015 Sep; 11(9):1121-2. PubMed ID: 25754460
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerating Medicines Partnership: Alzheimer's Disease (AMP-AD) Knowledge Portal Aids Alzheimer's Drug Discovery through Open Data Sharing.
    Hodes RJ; Buckholtz N
    Expert Opin Ther Targets; 2016; 20(4):389-91. PubMed ID: 26853544
    [No Abstract]   [Full Text] [Related]  

  • 3. Translational medicine lessons from flurizan's failure in Alzheimer's disease (AD) trial: Implication for future drug discovery and development for AD.
    Wan HI; Jacobsen JS; Rutkowski JL; Feuerstein GZ
    Clin Transl Sci; 2009 Jun; 2(3):242-7. PubMed ID: 20443898
    [No Abstract]   [Full Text] [Related]  

  • 4. Alzheimer's disease drug development: translational neuroscience strategies.
    Cummings JL; Banks SJ; Gary RK; Kinney JW; Lombardo JM; Walsh RR; Zhong K
    CNS Spectr; 2013 Jun; 18(3):128-38. PubMed ID: 23472637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New frontiers for collaborative research.
    Goldman M
    Sci Transl Med; 2013 Dec; 5(216):216ed22. PubMed ID: 24353157
    [No Abstract]   [Full Text] [Related]  

  • 6. Alzheimer's disease public-private partnerships: update 2014.
    Snyder HM; Kim H; Bain LJ; Egge R; Carrillo MC
    Alzheimers Dement; 2014 Nov; 10(6):873-80. PubMed ID: 25218016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease.
    ; Fargo KN; Aisen P; Albert M; Au R; Corrada MM; DeKosky S; Drachman D; Fillit H; Gitlin L; Haas M; Herrup K; Kawas C; Khachaturian AS; Khachaturian ZS; Klunk W; Knopman D; Kukull WA; Lamb B; Logsdon RG; Maruff P; Mesulam M; Mobley W; Mohs R; Morgan D; Nixon RA; Paul S; Petersen R; Plassman B; Potter W; Reiman E; Reisberg B; Sano M; Schindler R; Schneider LS; Snyder PJ; Sperling RA; Yaffe K; Bain LJ; Thies WH; Carrillo MC
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S430-52. PubMed ID: 25341459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease research in the context of the national plan to address Alzheimer's disease.
    Snyder HM; Hendrix J; Bain LJ; Carrillo MC
    Mol Aspects Med; 2015; 43-44():16-24. PubMed ID: 26096321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
    Jones-Davis DM; Buckholtz N
    Alzheimers Dement; 2015 Jul; 11(7):860-4. PubMed ID: 26194319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the efficacy of translational medicine by optimally integrating health care, academia and industry.
    Bornstein SR; Licinio J
    Nat Med; 2011 Dec; 17(12):1567-9. PubMed ID: 22146467
    [No Abstract]   [Full Text] [Related]  

  • 11. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
    Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
    Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public-private partnerships in translational medicine: concepts and practical examples.
    Luijten PR; van Dongen GA; Moonen CT; Storm G; Crommelin DJ
    J Control Release; 2012 Jul; 161(2):416-21. PubMed ID: 22465390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease.
    Alzheimer's Association Expert Advisory Workgroup on NAPA
    Alzheimers Dement; 2012 Jul; 8(4):357-71. PubMed ID: 22748940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowing the translational research gap: what needs to be done?
    Wolkowicz R
    Future Med Chem; 2015; 7(14):1843-6. PubMed ID: 26393393
    [No Abstract]   [Full Text] [Related]  

  • 15. The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community.
    Rodríguez-Gómez O; Rodrigo A; Iradier F; Santos-Santos MA; Hundemer H; Ciudin A; Sannemann L; Zwan M; Glaysher B; Wimo A; Bonn J; Johansson G; Rodriguez I; Alegret M; Gove D; Pinó S; Trigueros P; Kivipelto M; Mathews B; Ciudad A; Ferreira D; Bintener C; Gurruchaga M; Westman E; Belger M; Valero S; Maguire P; Krivec D; Kramberger M; Simó R; Garro IP; Visser PJ; Dumas A; Georges J; Jessen F; Winblad B; Shering C; Stewart N; Campo L; Boada M;
    Alzheimers Dement; 2019 Jun; 15(6):828-839. PubMed ID: 31076376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximizing the Alzheimer's Disease Neuroimaging Initiative II.
    Carrillo MC; Sanders CA; Katz RG
    Alzheimers Dement; 2009 May; 5(3):271-5. PubMed ID: 19362888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
    Liu E; Luthman J; Cedarbaum JM; Schmidt ME; Cole PE; Hendrix J; Carrillo MC; Jones-Davis D; Tarver E; Novak G; De Santi S; Soares HD; Potter WZ; Siemers E; Schwarz AJ
    Alzheimers Dement; 2015 Jul; 11(7):840-9. PubMed ID: 26194317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data sharing as the foundation of discovery: ADNI and breakthroughs in Alzheimer's disease.
    Travaglia A; Hoffmann S
    Alzheimers Dement; 2024 Oct; 20(10):7395-7398. PubMed ID: 39077997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four disruptive strategies for removing drug discovery bottlenecks.
    Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ
    Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.